News
Pat Woodward receives the 2024-2025 Harlan Hatcher Arts and Sciences Distinguished Faculty Award
2024-2025 Harlan Hatcher Arts and Sciences Distinguished Faculty Award The Hatcher Award recognizes a full professor in the College of Arts and Sciences who, over a period of years, has developed a…
Dehua Pei Receives Distinguished Scholar Award
Dehua Pei has been named a 2025 Distinguished Scholar! The Distinguished Scholar Award honors six faculty members who demonstrate scholarly activity, research or creative works which…
AU24 John S. Swenton Award for Outstanding Teaching
Please join me in congratulating the winners of the AU24 John S. Swenton Award for Outstanding Teaching! This award recognizes outstanding contributions by GTAs in our department each semester…
Turning Carbon Emissions into Methane Fuel
Click here for a write up on recent work by Dr. Tomaz Neves-Garcia, a postdoctoral researcher in the Baker group. Tomaz was one of the graduate students in the USP-OSU Dual Degree Program and…
Award Winner: Presidential Fellowship by the Graduate School 2024 competition
Congratulations, Meera Madhu (advisor: Bern Kohler), on being awarded the Presidential Fellowship by the Graduate School in the 2024 competition. The Presidential Fellowship is the most…
Chair of the ACS Division of Computer in Chemistry in 2026 (chair-elect in 2025)
Congratulations, John Herbert, on being selected as the Chair 2026 (Chair-elect ‘25) for the COMP division! In this position, John will help shape the direction of the division! Great news,…
OSU’s BSP Scholars for 2023-2024
Congratulations, Abby Fisk and Hariharan Kannan on being selected as OSU’s BSP Scholars for 2023-2024! A key activity for the BSP Scholars at OSU is to work with Prof. Maria Palazzi, OSU Department…
Two siRNA Firms Launch -- Judo Bio and City Therapeutics both want to go after tricky tissues
Two start-ups have launched to develop next-generation drugs using small interfering RNA (siRNA) to silence genes. To read more, click here.
Kotaro Nakanishi, a co-founder of a startup, City Therapeutics
Congratulations, Kotaro on being a co-founder of a startup, City Therapeutics! It launched with $135 million in financing to lead the future of RNAi-based medicine. Outstanding news! To read…